Read our patient-centered pieces on the latest science and research presented at SABCS

View this email in your browser ([link removed]) Subscribe to Breast Cancer Action's email list ([link removed])
[link removed]
Hi
John,
We’re reporting back from the San Antonio Breast Cancer Symposium (SABCS) on behalf of those living with and at risk of breast cancer.

As patient-centered advocates, we turn a critical eye toward the latest research and pharmaceutical developments when at SABCS, the world’s largest breast cancer conference.

The symposium ran from December 5th to December 9th of 2023 and took place both in-person in San Antonio, Texas, and in virtual format. BCAction team members who covered sessions throughout the 5-day conference were myself, BCAction’s Program Manager, Program Officer Zoë Christopher, and Executive Director KR, and we each brought our own lived experiences and analytical lenses to the topics we reported on.

Check out our #SABCS23 posts now, available on the following topics:
* SABCS 2023 Foreword ([link removed])
* Addressing the Social Determinants of Health ([link removed])
* Advancing Breast Cancer Health Equity Part I: Why Social Determinants of Health are Necessary for Improving Health Outcomes ([link removed])
* Advancing Breast Cancer Health Equity Part II: Social Determinants of Health (SDoH) and Proven Strategies to Address Health Disparities ([link removed])
* Clinical Updates: Impact of Race and Ethnicity on Recurrence Risk in Patients with Ductal Carcinoma in Situ Treated with Breast-Conserving Surgery ([link removed])
* Early Detection of Breast Cancer in People Who Are Pregnant: The Need for an Intersectional Approach ([link removed])
* Inflammatory Breast Cancer: Clinical Challenges, Evolving Concepts, and Novel Treatments ([link removed])
* Recent “Advances” in Triple Negative Breast Cancer ([link removed])
* Revolutionizing HER2-Positive Breast Cancer Treatment: A Closer Look at Trastuzumab Deruxtecan ([link removed])
* Solving the Intricate Puzzle: Updates in the Obesity-Breast Cancer Connection ([link removed])
* The Polygenic Risk Score: Necessary but Not Sufficient for Targeting Prevention Strategies ([link removed])
* Treating Triple-Negative Breast Cancer and Early Stage HER2+ Breast Cancer in Older Adults ([link removed])
* Understanding the Connections Between Hormone Replacement Therapy and Breast Cancer Risk ([link removed])

We also posted rapid-response takes on Instagram ([link removed]\) , where you can see our live feedback and developing thoughts on the research and developments as they were presented live.

Watchdogging Big Pharma and translating the latest science back to our community are two of our core priorities: and we do this work so that we as breast cancer activists can insist on patient- and people-centered practices, policies, science, and treatments. Thank you for joining us in this vision and this work.

In action with you,
Haleemah Atobiloye
Program Manager
Donate Today ([link removed])

============================================================
** Facebook ([link removed])
** Instagram ([link removed])
** Website (www.bcaction.org)
** YouTube ([link removed])
** Email (mailto:[email protected])
Copyright ©2024 Breast Cancer Action, All rights reserved.

Our mailing address is:
548 Market St
PMB 17179
San Francisco, California 94104-5401

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.